Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Coronary Occlusion | 70 | 2024 | 304 | 12.640 |
Why?
|
Drug-Eluting Stents | 55 | 2024 | 681 | 10.610 |
Why?
|
Platelet Aggregation Inhibitors | 67 | 2024 | 2751 | 8.820 |
Why?
|
Myocardial Infarction | 100 | 2024 | 11461 | 6.500 |
Why?
|
Coronary Artery Disease | 74 | 2024 | 6403 | 6.220 |
Why?
|
Medicare | 89 | 2024 | 6770 | 5.880 |
Why?
|
Aortic Valve Stenosis | 21 | 2024 | 2001 | 5.590 |
Why?
|
Coronary Restenosis | 17 | 2024 | 396 | 5.560 |
Why?
|
Patient Readmission | 38 | 2023 | 3271 | 5.340 |
Why?
|
Stents | 41 | 2024 | 3179 | 4.920 |
Why?
|
Registries | 120 | 2024 | 8224 | 4.550 |
Why?
|
Heart Valve Prosthesis Implantation | 12 | 2023 | 1553 | 3.860 |
Why?
|
Coronary Angiography | 81 | 2024 | 4471 | 3.430 |
Why?
|
Shock, Cardiogenic | 13 | 2023 | 709 | 3.400 |
Why?
|
Angioplasty, Balloon, Coronary | 18 | 2024 | 1725 | 3.260 |
Why?
|
Hemorrhage | 49 | 2023 | 3424 | 3.200 |
Why?
|
Angina Pectoris | 10 | 2022 | 959 | 3.190 |
Why?
|
Aortic Valve | 17 | 2024 | 1955 | 3.110 |
Why?
|
Peripheral Arterial Disease | 21 | 2024 | 1273 | 3.080 |
Why?
|
United States | 228 | 2024 | 72335 | 3.050 |
Why?
|
Treatment Outcome | 217 | 2024 | 64684 | 3.020 |
Why?
|
Hospital Mortality | 54 | 2024 | 5293 | 2.940 |
Why?
|
Femoral Artery | 19 | 2024 | 826 | 2.720 |
Why?
|
Aspirin | 29 | 2024 | 3133 | 2.710 |
Why?
|
Postoperative Hemorrhage | 8 | 2021 | 415 | 2.440 |
Why?
|
Risk Assessment | 90 | 2024 | 23996 | 2.410 |
Why?
|
Hospital Costs | 10 | 2019 | 947 | 2.410 |
Why?
|
Aged | 272 | 2024 | 169310 | 2.370 |
Why?
|
Paclitaxel | 12 | 2024 | 1732 | 2.270 |
Why?
|
Angioplasty | 9 | 2020 | 355 | 2.270 |
Why?
|
Cardiovascular Agents | 11 | 2024 | 840 | 2.230 |
Why?
|
Time Factors | 118 | 2024 | 39970 | 2.130 |
Why?
|
Mandatory Reporting | 7 | 2018 | 123 | 2.030 |
Why?
|
Angioplasty, Balloon | 7 | 2024 | 589 | 1.990 |
Why?
|
Humans | 502 | 2024 | 761572 | 1.990 |
Why?
|
Hospitals | 16 | 2023 | 3882 | 1.920 |
Why?
|
Thrombosis | 20 | 2023 | 2942 | 1.920 |
Why?
|
Embolic Protection Devices | 7 | 2024 | 42 | 1.910 |
Why?
|
Coronary Thrombosis | 14 | 2020 | 440 | 1.890 |
Why?
|
Acute Coronary Syndrome | 20 | 2023 | 2190 | 1.880 |
Why?
|
Risk Factors | 162 | 2024 | 74213 | 1.850 |
Why?
|
Quality Indicators, Health Care | 14 | 2024 | 1792 | 1.830 |
Why?
|
Cardiology | 11 | 2024 | 1656 | 1.810 |
Why?
|
Male | 303 | 2024 | 360842 | 1.720 |
Why?
|
Pneumonia | 12 | 2023 | 2143 | 1.720 |
Why?
|
Female | 304 | 2024 | 392686 | 1.650 |
Why?
|
Popliteal Artery | 8 | 2024 | 310 | 1.640 |
Why?
|
Heart-Assist Devices | 7 | 2023 | 1287 | 1.630 |
Why?
|
Coated Materials, Biocompatible | 8 | 2024 | 311 | 1.620 |
Why?
|
Coronary Artery Bypass | 21 | 2023 | 2188 | 1.610 |
Why?
|
Anticoagulants | 25 | 2024 | 4812 | 1.580 |
Why?
|
Aged, 80 and over | 91 | 2024 | 58986 | 1.560 |
Why?
|
Economics, Hospital | 5 | 2021 | 210 | 1.560 |
Why?
|
Stroke | 39 | 2024 | 9758 | 1.540 |
Why?
|
Coronary Vessels | 22 | 2020 | 3096 | 1.510 |
Why?
|
Myocardial Revascularization | 6 | 2019 | 790 | 1.490 |
Why?
|
Atrial Fibrillation | 19 | 2024 | 5127 | 1.480 |
Why?
|
Heart Valve Prosthesis | 6 | 2022 | 1462 | 1.450 |
Why?
|
Device Approval | 4 | 2023 | 163 | 1.450 |
Why?
|
Purinergic P2Y Receptor Antagonists | 4 | 2023 | 284 | 1.430 |
Why?
|
Ticlopidine | 11 | 2019 | 730 | 1.430 |
Why?
|
Pyridines | 14 | 2019 | 2875 | 1.420 |
Why?
|
Heart Failure | 30 | 2024 | 11670 | 1.400 |
Why?
|
Prosthesis Design | 17 | 2024 | 2115 | 1.370 |
Why?
|
Middle Aged | 212 | 2024 | 220920 | 1.340 |
Why?
|
Endovascular Procedures | 9 | 2023 | 2183 | 1.330 |
Why?
|
Hospitalization | 32 | 2024 | 10721 | 1.310 |
Why?
|
Drug Therapy, Combination | 32 | 2024 | 6312 | 1.280 |
Why?
|
Atrial Appendage | 8 | 2024 | 283 | 1.280 |
Why?
|
Postoperative Complications | 30 | 2024 | 15633 | 1.270 |
Why?
|
Decision Support Techniques | 12 | 2020 | 1998 | 1.240 |
Why?
|
Insurance Benefits | 3 | 2018 | 187 | 1.210 |
Why?
|
Retrospective Studies | 104 | 2024 | 80646 | 1.200 |
Why?
|
Comparative Effectiveness Research | 7 | 2016 | 709 | 1.190 |
Why?
|
Mitral Valve | 4 | 2020 | 1465 | 1.190 |
Why?
|
Disclosure | 4 | 2019 | 748 | 1.170 |
Why?
|
Mitral Valve Annuloplasty | 2 | 2020 | 144 | 1.160 |
Why?
|
Myocardial Ischemia | 8 | 2021 | 2113 | 1.140 |
Why?
|
Intra-Aortic Balloon Pumping | 2 | 2019 | 223 | 1.120 |
Why?
|
Fee-for-Service Plans | 8 | 2021 | 700 | 1.120 |
Why?
|
Healthcare Disparities | 15 | 2024 | 3358 | 1.100 |
Why?
|
Cardiovascular Diseases | 27 | 2023 | 15501 | 1.090 |
Why?
|
Radial Artery | 8 | 2020 | 187 | 1.090 |
Why?
|
Mitral Valve Insufficiency | 4 | 2022 | 1400 | 1.080 |
Why?
|
Chest Pain | 6 | 2024 | 1091 | 1.060 |
Why?
|
Medicaid | 14 | 2023 | 2818 | 1.060 |
Why?
|
Chronic Disease | 51 | 2024 | 9319 | 1.040 |
Why?
|
Health Policy | 6 | 2023 | 2684 | 1.020 |
Why?
|
Patient Discharge | 16 | 2024 | 3443 | 1.020 |
Why?
|
New York | 11 | 2020 | 874 | 0.990 |
Why?
|
Databases, Factual | 25 | 2022 | 7967 | 0.990 |
Why?
|
Quality Assurance, Health Care | 5 | 2015 | 2169 | 0.980 |
Why?
|
Cardiology Service, Hospital | 4 | 2020 | 239 | 0.940 |
Why?
|
Randomized Controlled Trials as Topic | 15 | 2023 | 10212 | 0.910 |
Why?
|
Carotid Stenosis | 6 | 2015 | 860 | 0.900 |
Why?
|
Incidence | 43 | 2024 | 21355 | 0.900 |
Why?
|
Pipecolic Acids | 6 | 2010 | 77 | 0.890 |
Why?
|
Absorbable Implants | 4 | 2021 | 338 | 0.880 |
Why?
|
Extracorporeal Membrane Oxygenation | 3 | 2019 | 1462 | 0.850 |
Why?
|
Pulmonary Embolism | 7 | 2024 | 2567 | 0.830 |
Why?
|
Hirudins | 5 | 2017 | 179 | 0.830 |
Why?
|
Quality of Health Care | 11 | 2023 | 4330 | 0.830 |
Why?
|
United States Social Security Administration | 1 | 2022 | 11 | 0.820 |
Why?
|
Eligibility Determination | 4 | 2024 | 421 | 0.820 |
Why?
|
Mortality | 12 | 2021 | 2901 | 0.820 |
Why?
|
Product Surveillance, Postmarketing | 8 | 2024 | 452 | 0.810 |
Why?
|
Parathyroid Neoplasms | 2 | 2021 | 242 | 0.800 |
Why?
|
Insurance Coverage | 5 | 2023 | 1940 | 0.800 |
Why?
|
Heparin | 11 | 2017 | 1634 | 0.780 |
Why?
|
Sirolimus | 6 | 2021 | 1533 | 0.780 |
Why?
|
International Classification of Diseases | 3 | 2022 | 909 | 0.760 |
Why?
|
Clinical Trials as Topic | 9 | 2024 | 8002 | 0.760 |
Why?
|
Biomedical Technology | 1 | 2023 | 211 | 0.750 |
Why?
|
Heart Valve Diseases | 2 | 2019 | 1027 | 0.750 |
Why?
|
Research Report | 4 | 2017 | 367 | 0.740 |
Why?
|
Coronary Stenosis | 2 | 2021 | 794 | 0.740 |
Why?
|
Septal Occluder Device | 1 | 2021 | 125 | 0.730 |
Why?
|
Endarterectomy, Carotid | 5 | 2014 | 555 | 0.720 |
Why?
|
Brain Ischemia | 5 | 2022 | 3049 | 0.720 |
Why?
|
Health Services Misuse | 2 | 2020 | 244 | 0.710 |
Why?
|
Antithrombins | 4 | 2017 | 294 | 0.710 |
Why?
|
Length of Stay | 9 | 2022 | 6426 | 0.710 |
Why?
|
Learning Curve | 2 | 2019 | 230 | 0.700 |
Why?
|
Propensity Score | 11 | 2021 | 1913 | 0.700 |
Why?
|
Cardiac Surgical Procedures | 9 | 2023 | 3627 | 0.700 |
Why?
|
Secondary Prevention | 4 | 2021 | 1475 | 0.690 |
Why?
|
Insurance, Health | 5 | 2021 | 2498 | 0.670 |
Why?
|
Receptors, Purinergic P2Y12 | 1 | 2020 | 115 | 0.660 |
Why?
|
Four-Dimensional Computed Tomography | 1 | 2020 | 141 | 0.650 |
Why?
|
Foramen Ovale, Patent | 1 | 2021 | 208 | 0.650 |
Why?
|
Episode of Care | 1 | 2019 | 128 | 0.640 |
Why?
|
Risk Adjustment | 6 | 2019 | 600 | 0.640 |
Why?
|
Peptide Fragments | 5 | 2017 | 5112 | 0.630 |
Why?
|
Venous Thrombosis | 2 | 2018 | 1303 | 0.630 |
Why?
|
Tissue Scaffolds | 3 | 2020 | 934 | 0.620 |
Why?
|
Protective Devices | 1 | 2018 | 72 | 0.620 |
Why?
|
Government Regulation | 1 | 2023 | 524 | 0.620 |
Why?
|
Information Dissemination | 3 | 2018 | 1126 | 0.610 |
Why?
|
Etomidate | 1 | 2020 | 185 | 0.610 |
Why?
|
Blood Vessel Prosthesis Implantation | 3 | 2023 | 1428 | 0.600 |
Why?
|
Hyperparathyroidism, Primary | 1 | 2020 | 163 | 0.600 |
Why?
|
Outpatients | 4 | 2024 | 1597 | 0.600 |
Why?
|
Aortic Valve Insufficiency | 1 | 2022 | 576 | 0.600 |
Why?
|
Multivariate Analysis | 17 | 2019 | 12059 | 0.590 |
Why?
|
Aerospace Medicine | 1 | 2018 | 95 | 0.590 |
Why?
|
Insurance, Health, Reimbursement | 2 | 2018 | 385 | 0.580 |
Why?
|
Comorbidity | 17 | 2024 | 10508 | 0.580 |
Why?
|
Survival Rate | 19 | 2022 | 12725 | 0.580 |
Why?
|
Hemostatic Techniques | 2 | 2016 | 112 | 0.580 |
Why?
|
Health Services Accessibility | 9 | 2023 | 5440 | 0.570 |
Why?
|
Patient Admission | 3 | 2021 | 1367 | 0.570 |
Why?
|
American Heart Association | 10 | 2024 | 1039 | 0.570 |
Why?
|
Reimbursement Mechanisms | 2 | 2020 | 667 | 0.570 |
Why?
|
Drug Costs | 4 | 2023 | 1183 | 0.560 |
Why?
|
Drug Utilization | 2 | 2020 | 1188 | 0.560 |
Why?
|
Follow-Up Studies | 34 | 2024 | 39107 | 0.560 |
Why?
|
Ankle Brachial Index | 1 | 2017 | 163 | 0.560 |
Why?
|
Diagnosis | 1 | 2017 | 157 | 0.550 |
Why?
|
Death, Sudden | 1 | 2018 | 301 | 0.550 |
Why?
|
Heart Arrest | 3 | 2019 | 1514 | 0.550 |
Why?
|
Massachusetts | 17 | 2020 | 8830 | 0.540 |
Why?
|
Vascular Surgical Procedures | 2 | 2017 | 1489 | 0.540 |
Why?
|
Population Surveillance | 2 | 2021 | 2598 | 0.530 |
Why?
|
Workload | 2 | 2019 | 844 | 0.530 |
Why?
|
Serine Proteinase Inhibitors | 1 | 2017 | 175 | 0.530 |
Why?
|
Myocardial Reperfusion | 1 | 2017 | 338 | 0.530 |
Why?
|
Pharmaceutical Preparations | 2 | 2021 | 1089 | 0.530 |
Why?
|
Cost Savings | 2 | 2019 | 913 | 0.530 |
Why?
|
Ventricular Function | 1 | 2018 | 406 | 0.530 |
Why?
|
Logistic Models | 20 | 2019 | 13255 | 0.520 |
Why?
|
Surgical Procedures, Operative | 2 | 2020 | 1924 | 0.520 |
Why?
|
Patient Identification Systems | 1 | 2016 | 75 | 0.510 |
Why?
|
Tricuspid Valve | 1 | 2018 | 410 | 0.500 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 5 | 2024 | 3245 | 0.500 |
Why?
|
Vena Cava Filters | 1 | 2018 | 261 | 0.500 |
Why?
|
Pericardial Effusion | 2 | 2023 | 247 | 0.500 |
Why?
|
Data Mining | 1 | 2020 | 551 | 0.500 |
Why?
|
Primary Prevention | 4 | 2024 | 1186 | 0.490 |
Why?
|
Health Status | 8 | 2021 | 4077 | 0.490 |
Why?
|
Thrombocytopenia | 8 | 2019 | 1182 | 0.490 |
Why?
|
Adrenergic beta-Antagonists | 2 | 2020 | 1241 | 0.480 |
Why?
|
United States Department of Veterans Affairs | 3 | 2023 | 928 | 0.480 |
Why?
|
Angina, Unstable | 1 | 2019 | 888 | 0.470 |
Why?
|
Ischemic Attack, Transient | 2 | 2019 | 882 | 0.470 |
Why?
|
Anti-Inflammatory Agents | 1 | 2024 | 1809 | 0.470 |
Why?
|
Selection Bias | 2 | 2017 | 359 | 0.470 |
Why?
|
Thrombectomy | 2 | 2019 | 705 | 0.470 |
Why?
|
Venous Thromboembolism | 2 | 2018 | 1866 | 0.460 |
Why?
|
Odds Ratio | 15 | 2021 | 9646 | 0.460 |
Why?
|
Hemodynamics | 3 | 2020 | 4160 | 0.460 |
Why?
|
Thrombolytic Therapy | 6 | 2022 | 2064 | 0.450 |
Why?
|
Hyperlipidemias | 3 | 2023 | 771 | 0.450 |
Why?
|
Intraoperative Complications | 5 | 2020 | 1166 | 0.450 |
Why?
|
Metals | 3 | 2019 | 719 | 0.450 |
Why?
|
Computers, Handheld | 1 | 2015 | 210 | 0.450 |
Why?
|
Catheter Ablation | 6 | 2024 | 2751 | 0.440 |
Why?
|
Dyspnea | 3 | 2018 | 1347 | 0.440 |
Why?
|
Alloys | 1 | 2014 | 110 | 0.440 |
Why?
|
Carotid Artery Diseases | 3 | 2015 | 877 | 0.440 |
Why?
|
Inpatients | 5 | 2022 | 2548 | 0.430 |
Why?
|
Reoperation | 3 | 2021 | 4303 | 0.430 |
Why?
|
Electronic Health Records | 5 | 2019 | 4811 | 0.430 |
Why?
|
Blood Loss, Surgical | 1 | 2017 | 638 | 0.430 |
Why?
|
Policy Making | 1 | 2017 | 542 | 0.430 |
Why?
|
Cost-Benefit Analysis | 11 | 2020 | 5492 | 0.430 |
Why?
|
Aortic Aneurysm, Abdominal | 1 | 2023 | 1228 | 0.430 |
Why?
|
Prognosis | 20 | 2021 | 29629 | 0.430 |
Why?
|
Veterans | 4 | 2023 | 2649 | 0.430 |
Why?
|
Chi-Square Distribution | 12 | 2017 | 3416 | 0.430 |
Why?
|
Hypolipidemic Agents | 1 | 2017 | 609 | 0.420 |
Why?
|
Access to Information | 2 | 2019 | 316 | 0.420 |
Why?
|
Language | 1 | 2022 | 1540 | 0.420 |
Why?
|
Antineoplastic Agents, Phytogenic | 4 | 2021 | 621 | 0.420 |
Why?
|
Internationality | 2 | 2018 | 1001 | 0.420 |
Why?
|
Models, Cardiovascular | 3 | 2015 | 981 | 0.420 |
Why?
|
Coronary Care Units | 1 | 2014 | 235 | 0.410 |
Why?
|
Hyperlipoproteinemia Type II | 1 | 2017 | 395 | 0.410 |
Why?
|
Hypnotics and Sedatives | 1 | 2020 | 1179 | 0.410 |
Why?
|
Coronary Disease | 4 | 2014 | 5914 | 0.400 |
Why?
|
Social Responsibility | 1 | 2015 | 386 | 0.400 |
Why?
|
Cohort Studies | 20 | 2023 | 41493 | 0.400 |
Why?
|
Diabetes Mellitus | 9 | 2023 | 5841 | 0.400 |
Why?
|
Severity of Illness Index | 16 | 2024 | 15843 | 0.390 |
Why?
|
Predictive Value of Tests | 21 | 2024 | 15266 | 0.390 |
Why?
|
Cross-Sectional Studies | 24 | 2024 | 26127 | 0.380 |
Why?
|
Academies and Institutes | 1 | 2013 | 318 | 0.380 |
Why?
|
Seasons | 1 | 2017 | 1520 | 0.380 |
Why?
|
Catheterization, Peripheral | 3 | 2020 | 343 | 0.380 |
Why?
|
Data Interpretation, Statistical | 4 | 2017 | 2691 | 0.380 |
Why?
|
Research Design | 6 | 2019 | 6180 | 0.380 |
Why?
|
Affect | 1 | 2019 | 1486 | 0.370 |
Why?
|
Ventricular Fibrillation | 1 | 2014 | 537 | 0.370 |
Why?
|
Interviews as Topic | 1 | 2018 | 2696 | 0.370 |
Why?
|
Blood Transfusion | 2 | 2015 | 1301 | 0.370 |
Why?
|
Kaplan-Meier Estimate | 9 | 2021 | 6484 | 0.370 |
Why?
|
Withholding Treatment | 2 | 2019 | 617 | 0.360 |
Why?
|
Atherosclerosis | 4 | 2022 | 3408 | 0.350 |
Why?
|
Electrocardiography | 6 | 2015 | 6377 | 0.350 |
Why?
|
Sex Factors | 9 | 2021 | 10553 | 0.350 |
Why?
|
Age Factors | 14 | 2021 | 18398 | 0.350 |
Why?
|
Patient-Centered Care | 2 | 2017 | 1421 | 0.350 |
Why?
|
Platelet Factor 4 | 3 | 2007 | 129 | 0.340 |
Why?
|
Vascular Patency | 4 | 2024 | 911 | 0.340 |
Why?
|
Patient Protection and Affordable Care Act | 4 | 2021 | 1188 | 0.340 |
Why?
|
Calcinosis | 1 | 2018 | 1469 | 0.340 |
Why?
|
Adenoma | 1 | 2020 | 2160 | 0.340 |
Why?
|
Risk | 8 | 2021 | 9610 | 0.330 |
Why?
|
Fractional Flow Reserve, Myocardial | 2 | 2023 | 323 | 0.330 |
Why?
|
Depression | 3 | 2019 | 8124 | 0.330 |
Why?
|
Hospital Bed Capacity | 3 | 2021 | 206 | 0.330 |
Why?
|
Cardiac Tamponade | 1 | 2010 | 175 | 0.330 |
Why?
|
Congresses as Topic | 3 | 2019 | 803 | 0.330 |
Why?
|
California | 4 | 2019 | 1430 | 0.320 |
Why?
|
Patient Selection | 7 | 2024 | 4244 | 0.320 |
Why?
|
Critical Illness | 2 | 2022 | 2723 | 0.320 |
Why?
|
Amiodarone | 2 | 2021 | 217 | 0.320 |
Why?
|
Adult | 49 | 2024 | 221203 | 0.320 |
Why?
|
Takotsubo Cardiomyopathy | 1 | 2010 | 123 | 0.310 |
Why?
|
Thoracic Surgery | 1 | 2015 | 722 | 0.310 |
Why?
|
Antihypertensive Agents | 3 | 2024 | 2024 | 0.310 |
Why?
|
Myocardial Perfusion Imaging | 1 | 2014 | 575 | 0.310 |
Why?
|
Quality Improvement | 4 | 2021 | 3801 | 0.310 |
Why?
|
Hospitals, Urban | 3 | 2022 | 500 | 0.310 |
Why?
|
Education, Medical, Continuing | 1 | 2013 | 823 | 0.310 |
Why?
|
Morbidity | 5 | 2021 | 1750 | 0.300 |
Why?
|
Prevalence | 13 | 2023 | 15732 | 0.300 |
Why?
|
Europe | 10 | 2019 | 3422 | 0.300 |
Why?
|
Thrombin | 2 | 2010 | 591 | 0.300 |
Why?
|
Attitude of Health Personnel | 3 | 2018 | 3889 | 0.290 |
Why?
|
Amyloid Neuropathies, Familial | 2 | 2020 | 151 | 0.290 |
Why?
|
Prospective Studies | 32 | 2023 | 54426 | 0.290 |
Why?
|
Algorithms | 7 | 2022 | 14032 | 0.290 |
Why?
|
Equipment Design | 7 | 2024 | 3511 | 0.290 |
Why?
|
Markov Chains | 3 | 2020 | 966 | 0.290 |
Why?
|
Michigan | 2 | 2019 | 339 | 0.280 |
Why?
|
Frail Elderly | 3 | 2023 | 765 | 0.270 |
Why?
|
Wounds and Injuries | 2 | 2018 | 2491 | 0.270 |
Why?
|
Drug Administration Schedule | 7 | 2019 | 4853 | 0.270 |
Why?
|
Carotid Arteries | 1 | 2011 | 941 | 0.270 |
Why?
|
Clinical Competence | 2 | 2019 | 4793 | 0.270 |
Why?
|
Anemia | 2 | 2019 | 1509 | 0.260 |
Why?
|
Health Status Disparities | 4 | 2021 | 1852 | 0.260 |
Why?
|
Heart Diseases | 5 | 2021 | 2781 | 0.260 |
Why?
|
Intensive Care Units | 5 | 2023 | 3744 | 0.260 |
Why?
|
Fibrinolytic Agents | 3 | 2021 | 2084 | 0.250 |
Why?
|
Reproducibility of Results | 11 | 2022 | 20099 | 0.250 |
Why?
|
Prosthesis Implantation | 2 | 2020 | 592 | 0.250 |
Why?
|
Punctures | 5 | 2020 | 366 | 0.250 |
Why?
|
Drug Utilization Review | 2 | 2016 | 248 | 0.250 |
Why?
|
Enoxaparin | 1 | 2007 | 391 | 0.240 |
Why?
|
Multicenter Studies as Topic | 2 | 2021 | 1702 | 0.240 |
Why?
|
Cause of Death | 8 | 2021 | 3683 | 0.240 |
Why?
|
Certification | 2 | 2018 | 418 | 0.240 |
Why?
|
Nutrition Surveys | 5 | 2024 | 1733 | 0.230 |
Why?
|
Warfarin | 3 | 2024 | 1483 | 0.230 |
Why?
|
Health Facility Closure | 1 | 2023 | 25 | 0.220 |
Why?
|
Social Class | 3 | 2024 | 2004 | 0.220 |
Why?
|
Health Services Research | 3 | 2020 | 1812 | 0.220 |
Why?
|
Florida | 3 | 2020 | 431 | 0.220 |
Why?
|
Tomography, Optical Coherence | 6 | 2016 | 2917 | 0.220 |
Why?
|
Quality of Life | 8 | 2021 | 13367 | 0.210 |
Why?
|
Quality-Adjusted Life Years | 2 | 2020 | 1722 | 0.210 |
Why?
|
Hypertension | 5 | 2023 | 8540 | 0.210 |
Why?
|
Plaque, Atherosclerotic | 4 | 2021 | 1533 | 0.210 |
Why?
|
Residence Characteristics | 4 | 2022 | 2094 | 0.210 |
Why?
|
Ischemia | 3 | 2022 | 1883 | 0.200 |
Why?
|
Benzoxazoles | 2 | 2020 | 90 | 0.200 |
Why?
|
Biomedical Research | 1 | 2018 | 3429 | 0.200 |
Why?
|
Ambulatory Care | 4 | 2024 | 2775 | 0.200 |
Why?
|
Double-Blind Method | 10 | 2018 | 12341 | 0.200 |
Why?
|
Consensus | 5 | 2020 | 3123 | 0.200 |
Why?
|
United States Food and Drug Administration | 2 | 2023 | 1664 | 0.200 |
Why?
|
Antibodies | 3 | 2007 | 2418 | 0.200 |
Why?
|
Dinucleoside Phosphates | 1 | 2022 | 72 | 0.200 |
Why?
|
Pacemaker, Artificial | 2 | 2023 | 807 | 0.190 |
Why?
|
Technology Transfer | 1 | 2021 | 42 | 0.190 |
Why?
|
Renal Dialysis | 3 | 2018 | 1796 | 0.190 |
Why?
|
Telemedicine | 1 | 2019 | 3052 | 0.190 |
Why?
|
Bed Occupancy | 1 | 2021 | 38 | 0.190 |
Why?
|
Recombinant Proteins | 5 | 2017 | 6534 | 0.190 |
Why?
|
Software | 1 | 2015 | 4434 | 0.190 |
Why?
|
Geriatric Assessment | 2 | 2019 | 1410 | 0.190 |
Why?
|
Hospitals, Teaching | 2 | 2018 | 1156 | 0.190 |
Why?
|
Nitroglycerin | 1 | 2022 | 329 | 0.180 |
Why?
|
Health Expenditures | 4 | 2023 | 2366 | 0.180 |
Why?
|
Health Care Costs | 4 | 2016 | 3242 | 0.180 |
Why?
|
Vascular System Injuries | 2 | 2017 | 246 | 0.180 |
Why?
|
Calgranulin A | 1 | 2021 | 80 | 0.180 |
Why?
|
Recovery of Function | 4 | 2019 | 2979 | 0.180 |
Why?
|
Calgranulin B | 1 | 2021 | 86 | 0.180 |
Why?
|
Heart Ventricles | 3 | 2022 | 3807 | 0.180 |
Why?
|
Observer Variation | 4 | 2015 | 2606 | 0.180 |
Why?
|
Thiophenes | 2 | 2015 | 569 | 0.180 |
Why?
|
Arginine | 6 | 2010 | 934 | 0.170 |
Why?
|
ROC Curve | 5 | 2020 | 3579 | 0.170 |
Why?
|
Hospitals, Rural | 1 | 2022 | 176 | 0.170 |
Why?
|
Medication Therapy Management | 2 | 2018 | 130 | 0.170 |
Why?
|
Acute Disease | 6 | 2021 | 7237 | 0.170 |
Why?
|
Aftercare | 5 | 2024 | 914 | 0.170 |
Why?
|
Treatment Failure | 2 | 2024 | 2644 | 0.170 |
Why?
|
Evidence-Based Medicine | 3 | 2024 | 3688 | 0.170 |
Why?
|
Program Evaluation | 3 | 2019 | 2495 | 0.170 |
Why?
|
Costs and Cost Analysis | 3 | 2022 | 1668 | 0.170 |
Why?
|
Models, Statistical | 5 | 2017 | 5079 | 0.170 |
Why?
|
Rural Health | 1 | 2021 | 296 | 0.170 |
Why?
|
Arteritis | 1 | 2021 | 158 | 0.160 |
Why?
|
Death | 1 | 2024 | 676 | 0.160 |
Why?
|
Catheterization, Swan-Ganz | 1 | 2019 | 86 | 0.160 |
Why?
|
Gastrostomy | 1 | 2022 | 323 | 0.160 |
Why?
|
Accidents, Aviation | 1 | 2018 | 15 | 0.160 |
Why?
|
Atherectomy | 1 | 2019 | 42 | 0.160 |
Why?
|
Anti-Arrhythmia Agents | 2 | 2021 | 774 | 0.160 |
Why?
|
Young Adult | 14 | 2023 | 59255 | 0.160 |
Why?
|
Coronary Circulation | 3 | 2020 | 1569 | 0.160 |
Why?
|
Scotland | 1 | 2019 | 143 | 0.160 |
Why?
|
Asia | 2 | 2019 | 619 | 0.160 |
Why?
|
Thienopyridines | 1 | 2018 | 9 | 0.160 |
Why?
|
Wit and Humor as Topic | 1 | 2018 | 31 | 0.160 |
Why?
|
Renal Insufficiency, Chronic | 4 | 2021 | 2243 | 0.160 |
Why?
|
Forecasting | 3 | 2017 | 2928 | 0.160 |
Why?
|
Proportional Hazards Models | 7 | 2021 | 12463 | 0.160 |
Why?
|
Barrett Esophagus | 1 | 2003 | 492 | 0.160 |
Why?
|
Tubulin Modulators | 1 | 2019 | 107 | 0.160 |
Why?
|
Consumer Product Safety | 1 | 2019 | 122 | 0.160 |
Why?
|
Tricuspid Valve Insufficiency | 1 | 2022 | 353 | 0.160 |
Why?
|
P-Selectin | 1 | 2021 | 597 | 0.150 |
Why?
|
Urban Health | 1 | 2021 | 532 | 0.150 |
Why?
|
Polyesters | 1 | 2020 | 373 | 0.150 |
Why?
|
Cardiomyopathies | 2 | 2020 | 1964 | 0.150 |
Why?
|
Democracy | 1 | 2018 | 27 | 0.150 |
Why?
|
Medicare Part D | 1 | 2023 | 355 | 0.150 |
Why?
|
Assisted Circulation | 1 | 2018 | 100 | 0.150 |
Why?
|
Models, Economic | 2 | 2019 | 716 | 0.150 |
Why?
|
Adolescent | 13 | 2022 | 88324 | 0.150 |
Why?
|
Russia | 4 | 2019 | 384 | 0.150 |
Why?
|
Government Programs | 1 | 2020 | 279 | 0.150 |
Why?
|
Feasibility Studies | 3 | 2018 | 5247 | 0.150 |
Why?
|
Diabetic Angiopathies | 2 | 2013 | 803 | 0.150 |
Why?
|
Blood Vessel Prosthesis | 1 | 2023 | 951 | 0.150 |
Why?
|
Aircraft | 1 | 2018 | 130 | 0.150 |
Why?
|
Cardiac Pacing, Artificial | 3 | 2012 | 866 | 0.150 |
Why?
|
Proton Pump Inhibitors | 1 | 2003 | 532 | 0.150 |
Why?
|
Computer Simulation | 3 | 2021 | 6241 | 0.140 |
Why?
|
Mammary Arteries | 1 | 2017 | 81 | 0.140 |
Why?
|
Snow | 1 | 2017 | 15 | 0.140 |
Why?
|
Medicare Part C | 1 | 2022 | 334 | 0.140 |
Why?
|
Needs Assessment | 2 | 2020 | 1139 | 0.140 |
Why?
|
Public Opinion | 2 | 2018 | 484 | 0.140 |
Why?
|
Ownership | 1 | 2019 | 339 | 0.140 |
Why?
|
Saphenous Vein | 1 | 2020 | 516 | 0.140 |
Why?
|
Sample Size | 2 | 2017 | 841 | 0.140 |
Why?
|
South America | 1 | 2017 | 179 | 0.140 |
Why?
|
Kidney Failure, Chronic | 3 | 2013 | 2472 | 0.140 |
Why?
|
Cerebrovascular Disorders | 2 | 2021 | 1474 | 0.140 |
Why?
|
Intention | 1 | 2019 | 347 | 0.140 |
Why?
|
Physician Incentive Plans | 1 | 2018 | 164 | 0.130 |
Why?
|
Atherectomy, Coronary | 1 | 2016 | 137 | 0.130 |
Why?
|
Blood Platelets | 3 | 2023 | 2479 | 0.130 |
Why?
|
Shock | 1 | 2018 | 314 | 0.130 |
Why?
|
New Jersey | 1 | 2016 | 295 | 0.130 |
Why?
|
Brachial Artery | 1 | 2017 | 366 | 0.130 |
Why?
|
Data Collection | 2 | 2015 | 3322 | 0.130 |
Why?
|
Cardiovascular System | 1 | 2023 | 834 | 0.130 |
Why?
|
Bioprosthesis | 1 | 2020 | 591 | 0.130 |
Why?
|
Insurance | 1 | 2017 | 113 | 0.130 |
Why?
|
Sweden | 1 | 2019 | 1379 | 0.130 |
Why?
|
Conscious Sedation | 1 | 2020 | 532 | 0.130 |
Why?
|
Critical Care | 2 | 2019 | 2697 | 0.130 |
Why?
|
Prescription Drugs | 1 | 2023 | 631 | 0.130 |
Why?
|
Ambulatory Surgical Procedures | 1 | 2020 | 464 | 0.130 |
Why?
|
Gastroesophageal Reflux | 1 | 2003 | 819 | 0.120 |
Why?
|
Peripheral Vascular Diseases | 3 | 2019 | 488 | 0.120 |
Why?
|
Organ Size | 1 | 2020 | 2254 | 0.120 |
Why?
|
Injury Severity Score | 1 | 2018 | 1045 | 0.120 |
Why?
|
Insurance, Pharmaceutical Services | 1 | 2017 | 348 | 0.120 |
Why?
|
Health Care Surveys | 2 | 2020 | 2426 | 0.120 |
Why?
|
Intracranial Hemorrhages | 2 | 2019 | 822 | 0.120 |
Why?
|
Peer Review, Research | 1 | 2018 | 340 | 0.120 |
Why?
|
Out-of-Hospital Cardiac Arrest | 1 | 2019 | 339 | 0.120 |
Why?
|
Hospitals, General | 2 | 2016 | 798 | 0.120 |
Why?
|
Referral and Consultation | 4 | 2022 | 3600 | 0.120 |
Why?
|
Ankle | 1 | 2017 | 351 | 0.120 |
Why?
|
Linear Models | 4 | 2021 | 5872 | 0.120 |
Why?
|
Employment | 1 | 2021 | 1118 | 0.120 |
Why?
|
Piperazines | 2 | 2015 | 2523 | 0.120 |
Why?
|
Ventricular Function, Left | 5 | 2023 | 3879 | 0.110 |
Why?
|
Sulfonamides | 6 | 2010 | 1978 | 0.110 |
Why?
|
Consumer Health Information | 1 | 2016 | 215 | 0.110 |
Why?
|
Coronary Vessel Anomalies | 1 | 2017 | 307 | 0.110 |
Why?
|
Truth Disclosure | 1 | 2018 | 434 | 0.110 |
Why?
|
Poverty | 3 | 2021 | 2698 | 0.110 |
Why?
|
Rural Population | 2 | 2022 | 2285 | 0.110 |
Why?
|
Stroke Volume | 6 | 2023 | 5496 | 0.110 |
Why?
|
Extremities | 1 | 2019 | 867 | 0.110 |
Why?
|
Defibrillators, Implantable | 1 | 2023 | 1490 | 0.110 |
Why?
|
Guidelines as Topic | 1 | 2020 | 1386 | 0.110 |
Why?
|
Collateral Circulation | 3 | 2020 | 294 | 0.110 |
Why?
|
Lower Extremity | 1 | 2021 | 1202 | 0.110 |
Why?
|
Patient Care Planning | 1 | 2019 | 909 | 0.110 |
Why?
|
Hospital Charges | 1 | 2015 | 350 | 0.110 |
Why?
|
North America | 1 | 2017 | 1276 | 0.110 |
Why?
|
Australia | 1 | 2017 | 1250 | 0.110 |
Why?
|
Discriminant Analysis | 1 | 2013 | 223 | 0.110 |
Why?
|
Aortic Aneurysm, Thoracic | 1 | 2019 | 696 | 0.110 |
Why?
|
Ultrasonography, Interventional | 4 | 2023 | 1496 | 0.110 |
Why?
|
Arteriosclerosis | 1 | 2017 | 1055 | 0.110 |
Why?
|
Lipids | 2 | 2022 | 3341 | 0.110 |
Why?
|
Anesthesia, General | 1 | 2020 | 1174 | 0.110 |
Why?
|
Ultrasonography, Doppler | 1 | 2015 | 462 | 0.100 |
Why?
|
Health Services | 1 | 2018 | 752 | 0.100 |
Why?
|
Program Development | 1 | 2019 | 1297 | 0.100 |
Why?
|
History, 21st Century | 2 | 2018 | 1567 | 0.100 |
Why?
|
Coronavirus Infections | 2 | 2020 | 3086 | 0.100 |
Why?
|
Carnitine | 1 | 2013 | 252 | 0.100 |
Why?
|
Pneumonia, Viral | 2 | 2020 | 3206 | 0.100 |
Why?
|
Sex Distribution | 1 | 2017 | 2281 | 0.100 |
Why?
|
Influenza, Human | 1 | 2023 | 1521 | 0.100 |
Why?
|
Income | 1 | 2021 | 1877 | 0.100 |
Why?
|
Boston | 4 | 2020 | 9326 | 0.100 |
Why?
|
Health Resources | 1 | 2018 | 935 | 0.100 |
Why?
|
Graft Occlusion, Vascular | 1 | 2015 | 537 | 0.100 |
Why?
|
Decision Making | 2 | 2017 | 3929 | 0.100 |
Why?
|
Neointima | 1 | 2012 | 133 | 0.100 |
Why?
|
Causality | 1 | 2017 | 1242 | 0.090 |
Why?
|
Survival Analysis | 2 | 2014 | 10090 | 0.090 |
Why?
|
Health Maintenance Organizations | 1 | 2014 | 659 | 0.090 |
Why?
|
Hospitals, Community | 1 | 2013 | 365 | 0.090 |
Why?
|
Pyridones | 1 | 2016 | 809 | 0.090 |
Why?
|
Resuscitation | 1 | 2015 | 673 | 0.090 |
Why?
|
Tetralogy of Fallot | 1 | 2016 | 618 | 0.090 |
Why?
|
History, 20th Century | 2 | 2018 | 2767 | 0.090 |
Why?
|
Postoperative Care | 3 | 2017 | 1468 | 0.090 |
Why?
|
Disease Progression | 3 | 2022 | 13510 | 0.090 |
Why?
|
Calcium | 2 | 2017 | 5722 | 0.090 |
Why?
|
Radiography, Interventional | 2 | 2018 | 1121 | 0.090 |
Why?
|
Heart | 2 | 2023 | 4404 | 0.090 |
Why?
|
Long-Term Care | 1 | 2014 | 633 | 0.090 |
Why?
|
Endocardium | 1 | 2011 | 248 | 0.090 |
Why?
|
Platelet Glycoprotein GPIIb-IIIa Complex | 2 | 2017 | 577 | 0.090 |
Why?
|
Constriction, Pathologic | 1 | 2014 | 1096 | 0.090 |
Why?
|
Preoperative Period | 1 | 2012 | 551 | 0.090 |
Why?
|
Minority Groups | 3 | 2022 | 1203 | 0.090 |
Why?
|
Liver Diseases | 1 | 2018 | 1298 | 0.090 |
Why?
|
Epidemiologic Methods | 1 | 2014 | 1336 | 0.080 |
Why?
|
Recurrence | 4 | 2021 | 8466 | 0.080 |
Why?
|
Practice Guidelines as Topic | 4 | 2024 | 7391 | 0.080 |
Why?
|
Radiation Injuries | 1 | 2016 | 1189 | 0.080 |
Why?
|
Patient Care Team | 1 | 2020 | 2521 | 0.080 |
Why?
|
Statistics as Topic | 1 | 2015 | 2358 | 0.080 |
Why?
|
Kidney Diseases | 2 | 2016 | 2091 | 0.080 |
Why?
|
Contrast Media | 3 | 2017 | 5311 | 0.080 |
Why?
|
Faculty, Medical | 1 | 2017 | 1204 | 0.080 |
Why?
|
Intracranial Embolism | 2 | 2024 | 189 | 0.080 |
Why?
|
Delivery of Health Care, Integrated | 1 | 2016 | 942 | 0.080 |
Why?
|
Comovirus | 1 | 2007 | 5 | 0.080 |
Why?
|
Insulin | 1 | 2022 | 6597 | 0.070 |
Why?
|
Drugs, Investigational | 1 | 2010 | 212 | 0.070 |
Why?
|
Heart Defects, Congenital | 2 | 2015 | 4671 | 0.070 |
Why?
|
Pandemics | 6 | 2023 | 8656 | 0.070 |
Why?
|
Atrioventricular Node | 1 | 2008 | 180 | 0.070 |
Why?
|
Emergency Medical Services | 1 | 2019 | 1923 | 0.070 |
Why?
|
Societies, Medical | 2 | 2016 | 3905 | 0.070 |
Why?
|
Metabolomics | 2 | 2013 | 1659 | 0.070 |
Why?
|
Health Promotion | 1 | 2019 | 2214 | 0.070 |
Why?
|
Antidepressive Agents | 1 | 2019 | 2897 | 0.070 |
Why?
|
Medication Adherence | 2 | 2019 | 2176 | 0.070 |
Why?
|
Dose-Response Relationship, Drug | 5 | 2018 | 10766 | 0.070 |
Why?
|
Guideline Adherence | 2 | 2013 | 2220 | 0.070 |
Why?
|
Arrhythmias, Cardiac | 1 | 2016 | 2244 | 0.070 |
Why?
|
Survivors | 1 | 2017 | 2371 | 0.070 |
Why?
|
Pyrazoles | 1 | 2016 | 2009 | 0.070 |
Why?
|
Body Mass Index | 4 | 2022 | 12954 | 0.060 |
Why?
|
Telomere | 1 | 2012 | 943 | 0.060 |
Why?
|
Suture Techniques | 1 | 2011 | 769 | 0.060 |
Why?
|
Academic Medical Centers | 1 | 2016 | 2759 | 0.060 |
Why?
|
Tachycardia | 1 | 2008 | 600 | 0.060 |
Why?
|
HIV Infections | 2 | 2023 | 17352 | 0.060 |
Why?
|
Blood Pressure | 1 | 2021 | 8481 | 0.060 |
Why?
|
Cardiac Resynchronization Therapy | 1 | 2011 | 555 | 0.060 |
Why?
|
Echocardiography | 2 | 2022 | 4989 | 0.060 |
Why?
|
Intention to Treat Analysis | 2 | 2017 | 413 | 0.060 |
Why?
|
Bayes Theorem | 1 | 2013 | 2330 | 0.060 |
Why?
|
Tomography, X-Ray Computed | 4 | 2016 | 20571 | 0.060 |
Why?
|
Primary Health Care | 1 | 2021 | 4686 | 0.060 |
Why?
|
Mental Health | 1 | 2019 | 3250 | 0.060 |
Why?
|
Health Behavior | 1 | 2016 | 2644 | 0.060 |
Why?
|
Cesarean Section | 1 | 2013 | 1398 | 0.060 |
Why?
|
Postoperative Period | 3 | 2017 | 1814 | 0.060 |
Why?
|
Leukocytes | 1 | 2012 | 2026 | 0.060 |
Why?
|
Life Style | 1 | 2015 | 3917 | 0.060 |
Why?
|
Japan | 2 | 2018 | 1378 | 0.050 |
Why?
|
Gastric Acidity Determination | 1 | 2003 | 56 | 0.050 |
Why?
|
Cardiomyopathy, Hypertrophic | 1 | 2012 | 1310 | 0.050 |
Why?
|
Child, Preschool | 2 | 2023 | 42230 | 0.050 |
Why?
|
Heart Transplantation | 2 | 2007 | 3233 | 0.050 |
Why?
|
Terminology as Topic | 1 | 2010 | 1530 | 0.050 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2017 | 3415 | 0.050 |
Why?
|
Emergency Service, Hospital | 2 | 2019 | 7879 | 0.050 |
Why?
|
Pregnancy Outcome | 1 | 2013 | 2922 | 0.050 |
Why?
|
Triage | 2 | 2021 | 986 | 0.050 |
Why?
|
Area Under Curve | 2 | 2016 | 1638 | 0.050 |
Why?
|
Nanotechnology | 1 | 2007 | 714 | 0.050 |
Why?
|
Polyethylene Glycols | 1 | 2007 | 1189 | 0.050 |
Why?
|
Rehabilitation Centers | 1 | 2023 | 246 | 0.050 |
Why?
|
Sotalol | 1 | 2021 | 47 | 0.050 |
Why?
|
Flecainide | 1 | 2021 | 41 | 0.050 |
Why?
|
Tachycardia, Ventricular | 1 | 2010 | 1304 | 0.050 |
Why?
|
Premature Birth | 1 | 2013 | 1782 | 0.050 |
Why?
|
Folic Acid | 1 | 2007 | 1323 | 0.040 |
Why?
|
Antibodies, Monoclonal | 1 | 2017 | 9177 | 0.040 |
Why?
|
Thromboembolism | 1 | 2007 | 995 | 0.040 |
Why?
|
Neprilysin | 1 | 2023 | 478 | 0.040 |
Why?
|
Carotid Artery, Common | 1 | 2021 | 175 | 0.040 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 1 | 2007 | 1222 | 0.040 |
Why?
|
Washington | 1 | 2020 | 315 | 0.040 |
Why?
|
Civil Defense | 1 | 2021 | 115 | 0.040 |
Why?
|
Gastric Mucosa | 1 | 2003 | 604 | 0.040 |
Why?
|
Population Density | 1 | 2020 | 193 | 0.040 |
Why?
|
Chromatography, Liquid | 2 | 2013 | 983 | 0.040 |
Why?
|
Paris | 1 | 2019 | 41 | 0.040 |
Why?
|
Ventricular Dysfunction, Left | 1 | 2010 | 2118 | 0.040 |
Why?
|
Fibrosis | 2 | 2019 | 2049 | 0.040 |
Why?
|
Limb Salvage | 1 | 2022 | 481 | 0.040 |
Why?
|
Smoking | 1 | 2016 | 9053 | 0.040 |
Why?
|
District of Columbia | 1 | 2019 | 159 | 0.040 |
Why?
|
Platelet Function Tests | 1 | 2021 | 271 | 0.040 |
Why?
|
CD40 Ligand | 1 | 2021 | 522 | 0.040 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2006 | 3810 | 0.040 |
Why?
|
Prealbumin | 1 | 2020 | 222 | 0.040 |
Why?
|
Hospitals, Veterans | 1 | 2021 | 395 | 0.040 |
Why?
|
Catheters | 1 | 2021 | 427 | 0.040 |
Why?
|
Intermittent Claudication | 1 | 2020 | 304 | 0.040 |
Why?
|
Pulmonary Veins | 1 | 2024 | 743 | 0.040 |
Why?
|
Retreatment | 1 | 2020 | 598 | 0.040 |
Why?
|
Pharynx | 1 | 2021 | 432 | 0.040 |
Why?
|
Carotid Artery, Internal | 1 | 2021 | 445 | 0.040 |
Why?
|
Hydrogen-Ion Concentration | 1 | 2003 | 2496 | 0.040 |
Why?
|
Health Care Rationing | 1 | 2021 | 437 | 0.040 |
Why?
|
Obesity | 4 | 2023 | 12947 | 0.040 |
Why?
|
Tracheostomy | 1 | 2022 | 426 | 0.040 |
Why?
|
Combined Modality Therapy | 2 | 2020 | 8528 | 0.040 |
Why?
|
New York City | 1 | 2020 | 731 | 0.040 |
Why?
|
Hospital Administration | 1 | 2021 | 353 | 0.040 |
Why?
|
Echocardiography, Transesophageal | 1 | 2023 | 1086 | 0.040 |
Why?
|
Hospitals, University | 1 | 2019 | 564 | 0.040 |
Why?
|
Patient Acceptance of Health Care | 2 | 2022 | 3205 | 0.040 |
Why?
|
Hypertension, Portal | 1 | 2019 | 226 | 0.040 |
Why?
|
Immunosuppressive Agents | 3 | 2015 | 4176 | 0.040 |
Why?
|
Antineoplastic Agents | 1 | 2020 | 13642 | 0.040 |
Why?
|
Socioeconomic Factors | 2 | 2021 | 7827 | 0.030 |
Why?
|
Disability Evaluation | 1 | 2024 | 1836 | 0.030 |
Why?
|
Esophagus | 1 | 2003 | 1033 | 0.030 |
Why?
|
Adenosine Monophosphate | 1 | 2018 | 231 | 0.030 |
Why?
|
Radiation Monitoring | 1 | 2017 | 103 | 0.030 |
Why?
|
Neck | 1 | 2021 | 734 | 0.030 |
Why?
|
Mass Spectrometry | 2 | 2013 | 2192 | 0.030 |
Why?
|
Lasers, Excimer | 1 | 2016 | 69 | 0.030 |
Why?
|
Vasoconstrictor Agents | 1 | 2019 | 654 | 0.030 |
Why?
|
Miniaturization | 1 | 2016 | 153 | 0.030 |
Why?
|
Rupture, Spontaneous | 1 | 2016 | 362 | 0.030 |
Why?
|
Nanoparticles | 1 | 2007 | 1959 | 0.030 |
Why?
|
Reimbursement, Incentive | 1 | 2021 | 543 | 0.030 |
Why?
|
Rupture | 1 | 2017 | 443 | 0.030 |
Why?
|
Vulnerable Populations | 1 | 2021 | 703 | 0.030 |
Why?
|
Adenosine Diphosphate | 1 | 2016 | 422 | 0.030 |
Why?
|
Workflow | 1 | 2020 | 851 | 0.030 |
Why?
|
Patient Education as Topic | 2 | 2016 | 2319 | 0.030 |
Why?
|
Drug Monitoring | 1 | 2021 | 962 | 0.030 |
Why?
|
Research Support as Topic | 1 | 2019 | 697 | 0.030 |
Why?
|
China | 1 | 2021 | 2374 | 0.030 |
Why?
|
Infant, Newborn | 3 | 2023 | 26198 | 0.030 |
Why?
|
Safety | 1 | 2019 | 1150 | 0.030 |
Why?
|
Canada | 1 | 2020 | 2122 | 0.030 |
Why?
|
Patients | 1 | 2021 | 907 | 0.030 |
Why?
|
Brazil | 1 | 2018 | 1230 | 0.030 |
Why?
|
Interdisciplinary Communication | 1 | 2020 | 931 | 0.030 |
Why?
|
Waiting Lists | 1 | 2019 | 765 | 0.030 |
Why?
|
Equipment Failure | 1 | 2016 | 578 | 0.030 |
Why?
|
Equipment Safety | 1 | 2014 | 249 | 0.030 |
Why?
|
Urban Population | 1 | 2022 | 2036 | 0.030 |
Why?
|
Polymers | 1 | 2021 | 1617 | 0.030 |
Why?
|
Health Knowledge, Attitudes, Practice | 2 | 2021 | 4016 | 0.030 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2017 | 12148 | 0.030 |
Why?
|
Medically Uninsured | 1 | 2019 | 836 | 0.030 |
Why?
|
Cholesterol | 1 | 2022 | 2904 | 0.030 |
Why?
|
Cold Temperature | 1 | 2017 | 785 | 0.030 |
Why?
|
Health Services Needs and Demand | 1 | 2021 | 1403 | 0.030 |
Why?
|
Time | 1 | 2014 | 546 | 0.030 |
Why?
|
Cooperative Behavior | 1 | 2020 | 1505 | 0.030 |
Why?
|
Uremia | 1 | 2013 | 201 | 0.030 |
Why?
|
Informed Consent | 1 | 2019 | 1008 | 0.030 |
Why?
|
Emergencies | 1 | 2019 | 1217 | 0.030 |
Why?
|
Transferases (Other Substituted Phosphate Groups) | 1 | 1992 | 36 | 0.030 |
Why?
|
Intraoperative Care | 1 | 2016 | 767 | 0.030 |
Why?
|
Furosemide | 1 | 2013 | 170 | 0.030 |
Why?
|
Gastrointestinal Hemorrhage | 1 | 2019 | 1116 | 0.030 |
Why?
|
Pulmonary Valve | 1 | 2016 | 411 | 0.030 |
Why?
|
Fluoroscopy | 1 | 2016 | 947 | 0.030 |
Why?
|
Health Care Reform | 1 | 2021 | 1247 | 0.030 |
Why?
|
Plant Lectins | 1 | 1992 | 103 | 0.020 |
Why?
|
Neoplasms | 2 | 2018 | 22173 | 0.020 |
Why?
|
San Francisco | 1 | 2011 | 162 | 0.020 |
Why?
|
Comprehension | 1 | 2016 | 621 | 0.020 |
Why?
|
Phosphotransferases | 1 | 1992 | 303 | 0.020 |
Why?
|
Self Care | 1 | 2016 | 796 | 0.020 |
Why?
|
Kidney Function Tests | 1 | 2013 | 679 | 0.020 |
Why?
|
Supine Position | 1 | 2011 | 205 | 0.020 |
Why?
|
Longitudinal Studies | 2 | 2019 | 14607 | 0.020 |
Why?
|
Radiation Dosage | 1 | 2019 | 1958 | 0.020 |
Why?
|
Meta-Analysis as Topic | 1 | 2016 | 1380 | 0.020 |
Why?
|
Administration, Oral | 1 | 2018 | 4021 | 0.020 |
Why?
|
Models, Organizational | 1 | 2014 | 546 | 0.020 |
Why?
|
Drug Approval | 1 | 2017 | 814 | 0.020 |
Why?
|
Anticholesteremic Agents | 1 | 2017 | 966 | 0.020 |
Why?
|
Diuretics | 1 | 2013 | 610 | 0.020 |
Why?
|
Glomerular Filtration Rate | 1 | 2018 | 2177 | 0.020 |
Why?
|
Ribs | 1 | 2011 | 252 | 0.020 |
Why?
|
Drug Combinations | 1 | 2016 | 2048 | 0.020 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2016 | 1516 | 0.020 |
Why?
|
Checklist | 1 | 2016 | 827 | 0.020 |
Why?
|
Feedback | 1 | 2013 | 791 | 0.020 |
Why?
|
Hyperplasia | 1 | 2012 | 1152 | 0.020 |
Why?
|
Calcium Channel Blockers | 1 | 2012 | 694 | 0.020 |
Why?
|
Electrodes | 1 | 2011 | 614 | 0.020 |
Why?
|
Accidental Falls | 1 | 2017 | 1068 | 0.020 |
Why?
|
Whole Blood Coagulation Time | 1 | 2008 | 30 | 0.020 |
Why?
|
Exercise Tolerance | 1 | 2013 | 836 | 0.020 |
Why?
|
Respiration, Artificial | 1 | 2019 | 2630 | 0.020 |
Why?
|
Emergency Treatment | 1 | 2012 | 496 | 0.020 |
Why?
|
Risk Reduction Behavior | 1 | 2014 | 1112 | 0.020 |
Why?
|
Sick Sinus Syndrome | 1 | 2008 | 44 | 0.020 |
Why?
|
Cholesterol, LDL | 1 | 2017 | 2382 | 0.020 |
Why?
|
Myocardium | 1 | 2021 | 4725 | 0.020 |
Why?
|
Chromatography | 1 | 2007 | 189 | 0.020 |
Why?
|
Public Health | 1 | 2021 | 2669 | 0.020 |
Why?
|
Azides | 1 | 2007 | 118 | 0.020 |
Why?
|
Case-Control Studies | 2 | 2016 | 22176 | 0.020 |
Why?
|
Oxygen Consumption | 1 | 2013 | 1866 | 0.020 |
Why?
|
Posture | 1 | 2011 | 957 | 0.020 |
Why?
|
Acute Kidney Injury | 1 | 2019 | 1924 | 0.020 |
Why?
|
Syncope | 1 | 2010 | 427 | 0.020 |
Why?
|
Telemetry | 1 | 2008 | 199 | 0.020 |
Why?
|
Alkynes | 1 | 2007 | 320 | 0.020 |
Why?
|
Ultrasonography | 1 | 2019 | 5972 | 0.020 |
Why?
|
Heart Function Tests | 1 | 2007 | 318 | 0.020 |
Why?
|
Catalysis | 1 | 2007 | 774 | 0.020 |
Why?
|
Qualitative Research | 1 | 2016 | 3023 | 0.020 |
Why?
|
Copper | 1 | 2007 | 369 | 0.020 |
Why?
|
Lymphocytes | 1 | 1992 | 2612 | 0.010 |
Why?
|
Drug Resistance | 1 | 2010 | 1596 | 0.010 |
Why?
|
Platelet Count | 1 | 2006 | 781 | 0.010 |
Why?
|
Pilot Projects | 1 | 2016 | 8633 | 0.010 |
Why?
|
Echocardiography, Doppler | 1 | 2007 | 897 | 0.010 |
Why?
|
Heart Conduction System | 1 | 2008 | 1007 | 0.010 |
Why?
|
Microscopy | 1 | 2007 | 903 | 0.010 |
Why?
|
Substance-Related Disorders | 1 | 2019 | 4420 | 0.010 |
Why?
|
Neovascularization, Pathologic | 1 | 2012 | 2644 | 0.010 |
Why?
|
Inflammation | 1 | 2021 | 10773 | 0.010 |
Why?
|
Sensitivity and Specificity | 2 | 2007 | 14666 | 0.010 |
Why?
|
Lymphocyte Activation | 1 | 1992 | 5485 | 0.010 |
Why?
|
Physician-Patient Relations | 1 | 2014 | 3249 | 0.010 |
Why?
|
Delivery of Health Care | 1 | 2018 | 5336 | 0.010 |
Why?
|
Ligands | 1 | 2007 | 3272 | 0.010 |
Why?
|
Blotting, Western | 1 | 2007 | 5035 | 0.010 |
Why?
|
Communication | 1 | 2014 | 3873 | 0.010 |
Why?
|
Radiography | 1 | 2011 | 6965 | 0.010 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2012 | 3359 | 0.010 |
Why?
|
Physicians | 1 | 2016 | 4591 | 0.010 |
Why?
|
Preoperative Care | 1 | 2007 | 2242 | 0.010 |
Why?
|
Infant | 1 | 2020 | 36192 | 0.010 |
Why?
|
Transplantation, Homologous | 1 | 2006 | 4807 | 0.010 |
Why?
|
Animals | 2 | 2007 | 168467 | 0.010 |
Why?
|
Heart Rate | 1 | 2006 | 4195 | 0.010 |
Why?
|
Lung | 1 | 2011 | 10002 | 0.010 |
Why?
|
Chromatography, DEAE-Cellulose | 1 | 1992 | 81 | 0.010 |
Why?
|
Enzyme Stability | 1 | 1992 | 219 | 0.010 |
Why?
|
Child | 1 | 2020 | 80156 | 0.010 |
Why?
|
Chromatography, Gel | 1 | 1992 | 645 | 0.010 |
Why?
|
Pregnancy | 1 | 2013 | 29876 | 0.010 |
Why?
|
Chromatography, Affinity | 1 | 1992 | 532 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2007 | 16986 | 0.010 |
Why?
|
Solubility | 1 | 1992 | 1091 | 0.010 |
Why?
|
Lectins | 1 | 1992 | 491 | 0.010 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2006 | 9002 | 0.010 |
Why?
|
Substrate Specificity | 1 | 1992 | 1791 | 0.000 |
Why?
|
Physiology | 1 | 1963 | 111 | 0.000 |
Why?
|
Biophysics | 1 | 1963 | 380 | 0.000 |
Why?
|
Mathematics | 1 | 1963 | 707 | 0.000 |
Why?
|
Computers | 1 | 1963 | 593 | 0.000 |
Why?
|
Nervous System | 1 | 1963 | 545 | 0.000 |
Why?
|
Biophysical Phenomena | 1 | 1963 | 320 | 0.000 |
Why?
|